TITLE

A Unified Theory of the Causes of Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma, with a Consequent Treatment Proposal for Long-Term Control and Possible Cure

AUTHOR(S)
Wheatley, Carmen
PUB. DATE
March 2002
SOURCE
Journal of Orthomolecular Medicine;2002 1st Quarter, Vol. 17 Issue 1, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Investigates the causes of multiple myeloma and monoclonal gammopathy of unknown significance (MGUS). Background on epidemiological, biochemical and genetic causes; Hypothesis on the fundamental cause of MGUS and multiple myeloma; Proposals for long-term treatment and control.
ACCESSION #
6798305

 

Related Articles

  • Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana. Landgren, Ola; Katzmann, Jerry A.; Hsing, Ann W.; Pfeiffer, Ruth M.; Kyle, Robert A.; Yeboah, Edward D.; Biritwum, Richard B.; Tetfey, Yao; Adjei, Andrew A.; Larson, Dirk R.; Dispenzieri, Angela; Melton III, L. Joseph; Goldin, Lynn R.; Mcmaster, Mary L.; Caporaso, Neil E.; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Dec2007, Vol. 82 Issue 12, p1468 

    OBJECTIVES: To determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS), a precursor of multiple myeloma (MM), in Ghanaian men vs white men and to test for evidence to support an underlying race-related predisposition of the 2-fold higher prevalence of MGUS in...

  • Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Haynes, Richard J.; Read, Simon; Collins, Graham P.; Darby, Sarah C.; Winearls, Christopher G. // Nephrology Dialysis Transplantation;Feb2010, Vol. 25 Issue 2, p419 

    Background. Myeloma is the second most common haematological malignancy and is a cause of severe acute kidney injury (serum creatinine ≥500 μmol/L) that has long been associated with a poor prognosis, although previous series have been small.

  • Pathogenesis and progression of monoclonal gammopathy of undetermined significance. Bladé, J.; Rosiñol, L.; Cibeira, M. T.; de Larrea, C. F. // Leukemia (08876924);Sep2008, Vol. 22 Issue 9, p1651 

    In Caucasians, monoclonal gammopathy of undetermined significance (MGUS) is an age-related condition with prevalence as high as 3% in persons older than 50 years. Compared with whites, blacks have around two- and threefold higher prevalence rates of MGUS and multiple myeloma (MM), respectively....

  • Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Fonti, R.; Del Vecchio, S.; Zannetti, A.; De Renzo, A.; Di Gennaro, F.; Catalano, L.; Califano, C.; Pace, L.; Rotoli, B.; Salvatore, M. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 2, p214 

    Abstract. In a previous study, we showed the ability of technetium-99m methoxyisobutylisonitrile ([sup 99m]Tc-MIBI) scan to identify active disease in patients with multiple myeloma (Eur J Nucl Med 1998; 25: 714-720). In particular, a semiquantitative score of the extension and intensity of bone...

  • Online CME Quiz Questions. Multiple Myeloma Precursor Disease.  // JAMA: Journal of the American Medical Association;12/1/2010, Vol. 304 Issue 21, p2421 

    A online continuing medical education (CME) quiz about multiple myeloma precursor disease is presented.

  • Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications. Corso, A.; Zappasodi, P.; Pascutto, C.; Bosoni, T.; Mangiacavalli, S.; Lorenzi, A.; Rusconi, C.; Lazzarino, M. // Annals of Hematology;Aug2003, Vol. 82 Issue 8, p487 

    Renal failure is one of the worst complications occurring in multiple myeloma (MM) patients. It does not affect survival if reverted by a prompt chemotherapy before the damage becomes irreversible; therefore, the early diagnosis of renal dysfunction is crucial. High and low molecular weight...

  • Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Fonseca, R; Oken, M M; Harrington, D; Bailey, R J; Van Wier, S A; Henderson, K J; Kay, N E; Van Ness, B; Greipp, P R; Dewald, G W // Leukemia (08876924);Jun2001, Vol. 15 Issue 6, p981 

    Deletions of the long arm of chromosome 13 (13q-) are observed in patients with multiple myeloma (MM), are rarely observed in the monoclonal gammopathy of undetermined significance (MGUS) and have been associated with a worsened prognosis in MM. However, no minimally deleted region in the 13q...

  • 4. From MGUS to symptomatic MM.  // Hematology Journal;2003 Supplement, Vol. 4 Issue 1, pS31 

    The Hematology Journal (2003) 4, S31-S34. doi:10.1038/sj.thj.6200271

  • Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Woitge, H W; Pecherstorfer, M; Horn, E; Keck, A-V; Diel, I J; Bayer, P; Ludwig, H; Ziegler, R; Seibel, M J // British Journal of Cancer;2/1/2001, Vol. 84 Issue 3, p344 

    To test the potential of immunoreactive BSP, a non-collagenous bone matrix component, as a clinical guide in patients with plasma cell dyscrasias, serum BSP concentrations were measured in 62 patients with newly diagnosed multiple myeloma (MM) followed over a period of 4 years, in 46 patients...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics